½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting







»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹CLN5¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹CLN5¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW14908
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·


ÖÐÎÄÃû³Æ£ºÍÿ¹CLN5¶à¿Ë¡¿¹Ìå 

Ó¢ÎÄÃû³Æ£ºAnti-CLN5 rabbit polyclonal antibody

±ð      Ãû£ºceroid-lipofuscinosis, neuronal 5; NCL

Ïà¹ØÀà±ð£ºÒ»¿¹

¿¹      Ô­£ºCLN5

´¢      ´æ£ºÀä¶³£¨-20¡æ£©

ËÞ      Ö÷£ºRabbit

·´Ó¦ÖÖÊô£ºHuman, Mouse

±ê ¼Ç ÎUnconjugate

¿Ë¡ÀàÐÍ£ºrabbit polyclonal

¼¼Êõ¹æ¸ñ

Background:

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.

Applications:

ELISA, WB, IHC

Name of antibody:

CLN5

Immunogen:

Synthetic peptide of human CLN5

Full name:

ceroid-lipofuscinosis, neuronal 5

Synonyms:

NCL

SwissProt:

O75503

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer

IHC Recommend dilution:

40-200

WB Predicted band size:

41 kDa

WB Positive control:

231 cell lysate

WB Recommended dilution:

200-1000







¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿


¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿